Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Optum and Merck will collaborate to develop and simulate the performance of contractual reimbursement models in which payment for prescription drugs is aligned more closely with patient health outcomes.
read more
Frontida BioPharm announced the FDA issued a closure letter for its Philadelphia manufacturing site.
read more
BioPharma Services announced it has successfully completed three inspections this month by the FDA, with concurrent audits at both research centers in Toronto, Canada, and Columbia, Missouri.
read more
ProSciento announced the appointment of Dr. Kelvin Logan, former President of Europe, Asia and Latin America at INC Research, to its Board of Directors.
read more
Churchill Pharmaceuticals announced the expansion of their Commercial Leadership Team.
read more
Bluebee announced a strategic partnership to provide customers with tailored end-to-end analytical solutions for Next Generation Sequencing data.
read more
Orchard Therapeutics has entered a new clinical manufacturing services agreement with PCT Cell Therapy Services.
read more
Janssen has entered into a worldwide exclusive license and collaboration agreement with Protagonist to develop, manufacture, and commercialize PTG-200.
read more
Vetter and Microdermics announced that they have entered into a strategic cooperation agreement.
read more
Chiltern has acquired Integrated Development Associates, a CRO specializing in integrating Japan and Asia into global drug development.
read more
Caelum Biosciences has entered a biopharmaceutical manufacturing agreement with Patheon for process development and current cGMP production of Caelum’s lead therapy CAEL-101.
read more
Envigo has announced that its Research Models and Services facility in Hyderabad, India has been granted full accreditation by the AAALAC International Council.
read more
Accenture will acquire LabAnswer, a U.S.-based research and laboratory informatics technology consulting firm. Terms of the acquisition were not disclosed.
read more
Ligand Pharmaceuticals has entered into a worldwide license agreement with Cambridge, Massachusetts-based Surface Oncology.
read more
Bristol-Myers Squibb and QIAGEN signed an agreement to explore the use of NGS technology to develop GEPs as predictive or prognostic tools for use with Bristol-Myers Squibb novel I-O therapies in cancer treatment.
read more